284
Views
19
CrossRef citations to date
0
Altmetric
Drug Profiles

Buprenorphine – the unique opioid adjuvant in regional anesthesia

, &
Pages 375-383 | Received 01 Sep 2015, Accepted 08 Jan 2016, Published online: 28 Jan 2016

References

  • Pergolizzi J, Aloisi AM, Dahan A, et al. Current knowledge of buprenorphine and its unique pharmacological profile. Pain Pract. 2010;10:428–50.
  • Butler S. Buprenorphine – clinically useful but often misunderstood. Scand J Pain. 2013;4:148–52.
  • Cox BM, Christie MJ, Devi L, et al. Challenges for opioid receptor nomenclature: IUPHAR Review 9. Br J Pharmacol. 2015;172:317–323.
  • Davis MP. Twelve reasons for considering buprenorphine as a frontline analgesic in the management of pain. J Support Oncol. 2012;10:209–219.
  • Elkader A, Sproule B. Buprenorphine: clinical pharmacokinetics in the treatment of opioid dependence. Clin Pharmacokinet. 2005;44:661–680.
  • Kuhlman JJ Jr, Lalani S, Magluilo J Jr, et al. Human pharmacokinetics of intravenous, sublingual, and buccal buprenorphine. J Anal Toxicol. 1996;20:369–378.
  • Yassen A, Olofsen E, Romberg R, et al. Mechanism-based pharmacokinetic-pharmacodynamic modeling of the antinociceptive effect of buprenorphine in healthy volunteers. Anesthesiology. 2006;104:1232–1242.
  • Moody DE. Metabolic and toxicological considerations of the opioid replacement therapy and analgesic drugs: methadone and buprenorphine. Expert Opin Drug Metab Toxicol. 2013;9:675–97.
  • Brown SM, Holtzman M, Kim T, et al. Buprenorphine metabolites, buprenorphine-3-glucuronide and norbuprenorphine-3-glucuronide, are biologically active. Anesthesiology. 2011;115:1251–1260.
  • Mégarbane B, Marie N, Pirnay S, et al. Buprenorphine is protective against the depressive effects of norbuprenorphine on ventilation. Toxicol Appl Pharmacol. 2006;212:256–267.
  • Hand CW, Sear JW, Uppington J, et al. Buprenorphine disposition in patients with renal impairment: single and continuous dosing, with special reference to metabolites. Br J Anaesth. 1990;64:276–282.
  • Ing Lorenzini K, Daali Y, Dayer P, et al. Pharmacokinetic-pharmacodynamic modelling of opioids in healthy human volunteers. Basic Clin Pharmacol Toxicol. 2012;110:219–226.
  • Escher M, Daali Y, Chabert J, et al. Pharmacokinetic and pharmacodynamic properties of buprenorphine after a single intravenous administration in healthy volunteers: a randomized, double-blind, placebo-controlled, crossover study. Clin Ther. 2007;29:1620–1631.
  • Depriest A, Heltsley R, Black DL, et al. Urine drug testing of chronic pain patients. III. Normetabolites as biomarkers of synthetic opioid use. J Anal Toxicol. 2010;34:444–449.
  • Johnson RE, Jones RT, Fischer G. Use of buprenorphine in pregnancy: patient management and effects on the neonate. Drug Alcohol Depend. 2003;70:87–101.
  • Bruce RD, Moody DE, Altice FL, et al. A review of pharmacological interactions between HIV or hepatitis C virus medications and opioid agonist therapy: implications and management for clinical practice. Expert Rev Clin Pharmacol. 2013;6:249–69.
  • McCance-Katz EF, Sullivan L, Nallani S. Drug interactions of clinical importance among the opioids, methadone and buprenorphine, and other frequently prescribed medications: A review. Am J Addict. 2010;19:4–16.
  • Pöpping DM, Elia N, Marret E, et al. Opioids added to local anesthetics for single-shot intrathecal anesthesia in patients undergoing minor surgery: a meta-analysis of randomized trials. Pain. 2012;153:784–793.
  • Meylan N, Elia N, Lysakowski C, et al. Benefit and risk of intrathecal morphine without local anaesthetic in patients undergoing major surgery: meta-analysis of randomized trials. Br J Anaesth. 2009;102:156–167.
  • Bujedo BM, Santos SG, Azpiazu AU. A review of epidural and intrathecal opioids used in the management of postoperative pain. J Opioid Manag. 2012;8:177–192.
  • Russell NJ, Schaible HG, Schmidt RF. Opiates inhibit the discharges of fine afferent units from inflamed knee joint of the cat. Neurosci Lett. 1987;76:107–112.
  • Sehgal N, Smith HS, Manchikanti L. Peripherally acting opioids and clinical implications for pain control. Pain Physician. 2011;14:249–58.
  • Stein C, Küchler S. Targeting inflammation and wound healing by opioids. Trends Pharmacol Sci. 2013;34:303–312.
  • Iwaszkiewicz KS, Schneider JJ, Hua S. Targeting peripheral opioid receptors to promote analgesic and anti-inflammatory actions. Front Pharmacol. 2013;24:132.
  • Gupta A, Bodin L, Holmström B, et al. A systematic review of the peripheral analgesic effects of intraarticular morphine. Anesth Analg. 2001;93:761–770.
  • Likar R, Koppert W, Blatnig H, et al. Efficacy of peripheral morphine analgesia in inflamed, non-inflamed and perineural tissue of dental surgery patients. J Pain Symptom Manage. 2001;21:330–337.
  • Reuben SS, Vieira P, Faruqi S, et al. Local administration of morphine for analgesia after iliac bone graft harvest. Anesthesiology. 2001;95:390–394.
  • Mays KS, Lipman JJ, Schnapp M. Local analgesia without anesthesia using peripheral perineural morphine injections. Anesth Analg. 1987;66:417–420.
  • Bailard NS, Ortiz J, Flores RA. Additives to local anesthetics for peripheral nerve blocks: Evidence, limitations, and recommendations. Am J Health Syst Pharm. 2014;71:373–85.
  • Laduron PM, Janssen PF. Retrograde axonal transport of receptor-bound opiate in the vagus and delayed accumulation in the nodose ganglion. Brain Res. 1985;333:389–392.
  • Leffler A, Frank G, Kistner K, et al. Local anesthetic-like inhibition of voltage-gated Na(+) channels by the partial μ-opioid receptor agonist buprenorphine. Anesthesiology. 2012;116:1335–46.
  • Takahashi T, Okubo K, Kojima S, et al. Antihyperalgesic effect of buprenorphine involves nociceptin/orphanin FQ peptide-receptor activation in rats with spinal nerve injury-induced neuropathy. J Pharmacol Sci. 2013;122:51–54.
  • Koppert W, Ostermeier N, Sittl R, et al. Low-dose lidocaine reduces secondary hyperalgesia by a central mode of action. Pain. 2000;85:217–224.
  • Capogna G, Celleno D, Tagariello V, et al. Intrathecal buprenorphine for postoperative analgesia in the elderly patient. Anaesthesia. 1988;43:128–130.
  • Khan FA, Hamdani GA. Comparison of intrathecal fentanyl and buprenorphine in urological surgery. J Pak Med Assoc. 2006;56:277–281.
  • Sen M. Intrathecal buprenorphine for postoperative analgesia in orthopaedic surgery. J Indian Med Assoc. 1992;90:5–6.
  • Sapkal Pravin S, Kulkarni Kalyani D, Rajurkar Sampda S, et al. Comparative study of intrathecal clonidine and intrathecal buprenorphine for postoperative analgesia after lower limb orthopedic surgery. IJCRR. 2013;5:87–91.
  • Gupta M, Shailaja S, Hegde KS. Comparison of intrathecal dexmedetomidine with buprenorphine as adjuvant to bupivacaine in spinal asnaesthesia. J Clin Diagn Res. 2014;8:114–117.
  • Dahm PO, Nitescu PV, Appelgren LK, et al. Intrathecal infusion of bupivacaine with or without buprenorphine relieved intractable pain in three patients with vertebral compression fractures caused by osteoporosis. Reg Anesth Pain Med. 1999;24:352–357.
  • Dahm PO, Nitescu PV, Appelgren LK, et al. Six years of continuous intrathecal infusion of opioid and bupivacaine in the treatment of refractory pain due to intrapelvic extrusion of bone cement after total hip arthroplasty. Reg Anesth Pain Med. 1998;23:315–319.
  • Bromage PR, Camporesi E, Chestnut D. Epidural narcotics for postoperative analgesia. Anesth Analg. 1980;59:473–480.
  • Youssef N, Orlov D, Alie T, et al. What epidural opioid results in the best analgesia outcomes and fewest side effects after surgery?: a meta-analysis of randomized controlled trials. Anesth Analg. 2014;119:965–977.
  • Cahill J, Murphy D, O’Brien D, et al. Epidural buprenorphine for pain relief after major abdominal surgery. A controlled comparison with epidural morphine. Anaesthesia. 1983;38:760–764.
  • Wolff J, Carl P, Crawford ME. Epidural buprenorphine for postoperative analgesia. A controlled comparison with epidural morphine. Anaesthesia. 1986;41:76–79.
  • Knape JT. Early respiratory depression resistant to naloxone following epidural buprenorphine. Anesthesiology. 1986;64:382–384.
  • van Dorp E, Yassen A, Sarton E, et al. Naloxone reversal of buprenorphine-induced respiratory depression. Anesthesiology. 2006;105:51–57.
  • Inagaki Y, Mashimo T, Yoshiya I. Mode and site of analgesic action of epidural buprenorphine in humans. Anesth Analg. 1996;83:530–536.
  • Mishra LD, Nath SS, Gairola RL, et al. Buprenorphine-soaked absorbable gelatin sponge: an alternative method for postlaminectomy pain relief. J Neurosurg Anesthesiol. 2004;16:115–121.
  • Desai PM. Pain relief in chronic pancreatitis with epidural buprenorphine injection. Indian J Gastroenterol. 1997;16:12–13.
  • Zenz M, Piepenbrock S, Tryba M. Epidural opiates: long-term experiences in cancer pain. Klin Wochenschr. 1985;63:225–229.
  • Varrassi G, Marinangeli F, Ciccozzi A, et al. Intra-articular buprenorphine after knee arthroscopy. A randomised, prospective, double-blind study. Acta Anaesthesiol Scand. 1999;43:51–55.
  • Fellahi JL, Magues JP, Marquer B, et al. Analgesia with intra-articular injection of buprenorphine after surgery of the shoulder [Article in French]. Cah Anesthesiol. 1995;43:313–318.
  • Flamer D, Peng PW. Intravenous regional anesthesia: a review of common local anesthetic options and the use of opioids and muscle relaxants as adjuncts. Local Reg Anesth. 2011;4:57–76.
  • Swarnkar N, Ghosh A, Yadav A. Buprenorphine significantly prolongs postoperative analgesia in intravenous regional anesthesia: a double blind randomized clinical trial. Internet J Anesthesiol. 2008;19:5.
  • Brummett CM, Williams BA. Additives to local anesthetics for peripheral nerve blockade. Int Anesthesiol Clin. 2011;49:104–116.
  • Viel EJ, Eledjam JJ, De La Coussaye JE, et al. Brachial plexus block with opioids for postoperative pain relief: comparison between buprenorphine and morphine. Reg Anesth. 1989;14:274–278.
  • Bazin JE, Massoni C, Bruelle P, et al. The addition of opioids to local anaesthetics in brachial plexus block: the comparative effects of morphine, buprenorphine and sufentanil. Anaesthesia. 1997;52:858–862.
  • Candido KD, Franco CD, Khan MA, et al. Buprenorphine added to the local anesthetic for brachial plexus block to provide postoperative analgesia in outpatients. Reg Anesth Pain Med. 2001;26:352–356.
  • Candido KD, Winnie AP, Ghaleb AH, et al. Buprenorphine added to the local anesthetic for axillary brachial plexus block prolongs postoperative analgesia. Reg Anesth Pain Med. 2002;27:162–167.
  • Behr A, Freo U, Ori C, et al. Buprenorphine added to levobupivacaine enhances postoperative analgesia of middle interscalene brachial plexus block. J Anesth. 2012;26:746–751.
  • Alemanno F, Westermann B, Bettoni A, et al. Buprenorphine versus tramadol as perineural adjuvants for postoperative analgesia in patients undergoing arthroscopic rotator cuff repair under middle interscalene block: a retrospective study. Minerva Anestesiol. 2014;80:1198–1204.
  • Candido KD, Hennes J, Gonzalez S, et al. Buprenorphine enhances and prolongs the postoperative analgesic effect of bupivacaine in patients receiving infragluteal sciatic nerve block. Anesthesiology. 2010;113:1419–1426.
  • Kosel J, Bobik P, Siemiątkowski A. Buprenorphine added to bupivacaine prolongs femoral nerve block duration and improves analgesia in patients undergoing primary total knee arthroplasty – a randomised prospective double-blind study. J Arthroplasty. 2015;30:320–324.
  • Modi M, Rastogi S, Kumar A. Buprenorphine with bupivacaine for intraoral nerve blocks to provide postoperative analgesia in outpatients after minor oral surgery. J Oral Maxillofac Surg. 2009;67:2571–2576.
  • Gelfand HJ, Ouanes JP, Lesley MR, et al. Analgesic efficacy of ultrasound-guided regional anesthesia: a meta-analysis. J Clin Anesth. 2011;23:90–96.
  • Noviasky J, Pierce DP, Whalen K, et al. Bupivacaine liposomal versus bupivacaine: comparative review. Hosp Pharm. 2014;49:539–543.
  • Banerjee M, Baranwal A, Saha S, et al. EN3427: a novel cationic aminoindane with long-acting local anesthetic properties. Anesth Analg. 2015;120:941.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.